CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,188 | -41.4% | 1,574 | -38.0% | 0.00% | – |
| Q2 2023 | $3,734 | -84.6% | 2,540 | -82.7% | 0.00% | – |
| Q1 2023 | $24,238 | +1020.1% | 14,690 | +850.2% | 0.00% | – |
| Q4 2022 | $2,164 | +8.2% | 1,546 | +7.3% | 0.00% | – |
| Q3 2022 | $2,000 | -50.0% | 1,441 | -16.3% | 0.00% | – |
| Q2 2022 | $4,000 | -92.6% | 1,722 | -92.1% | 0.00% | – |
| Q1 2022 | $54,000 | – | 21,698 | +361533.3% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 6 | -100.0% | 0.00% | – |
| Q1 2021 | $1,387,000 | -90.9% | 149,780 | -82.3% | 0.00% | -100.0% |
| Q4 2020 | $15,263,000 | +9.8% | 848,400 | -13.4% | 0.00% | 0.0% |
| Q3 2020 | $13,898,000 | – | 979,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 45,000 | $63 | 0.04% |
| FinDec Wealth Services, Inc. | 16,000 | $22,240 | 0.02% |
| DENVER WEALTH MANAGEMENT, INC. | 18,235 | $25,347 | 0.02% |
| Atom Investors LP | 18,298 | $25,434 | 0.01% |
| Laurion Capital Management LP | 722,100 | $1,003,719 | 0.01% |
| MAI Capital Management | 224,749 | $312,401 | 0.01% |
| Callan Capital, LLC | 31,147 | $43,294 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 25,975 | $36 | 0.00% |
| Tortoise Investment Management, LLC | 15,000 | $20,850 | 0.00% |
| America First Investment Advisors, LLC | 4,000 | $5,560 | 0.00% |